Tempest Therapeutics, Inc. Common Stock TPST

$1.06 -1.85% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-08-24 View →
S-1 S-1 2026-08-21 View →
8-K 8-K 2026-08-18 View →
10-Q 10-Q 2026-08-13 View →
8-K 8-K 2026-08-13 View →
8-K 8-K 2026-08-13 View →
8-K 8-K 2026-07-28 View →
8-K 8-K 2026-07-22 View →
DEF 14A DEF 14A 2026-07-17 View →
S-3 S-3 2026-06-26 View →
4 4 2026-06-23 View →
8-K 8-K 2026-06-23 View →
4 4 2026-06-17 View →
4 4 2026-06-08 View →
DEF 14A DEF 14A 2026-06-08 View →
8-K 8-K 2026-06-04 View →
8-K 8-K 2026-06-02 View →
8-K 8-K 2026-05-29 View →
8-K 8-K 2026-05-22 View →
8-K 8-K 2026-05-22 View →
10-Q 10-Q 2026-05-14 View →
8-K 8-K 2026-05-14 View →
8-K 8-K 2026-05-06 View →
4 Insider transaction 2026-04-02 View →
4 Insider transaction 2026-04-02 View →
S-3 S-3 2026-04-02 View →
S-3 S-3 2026-03-30 View →
10-K 10-K 2026-03-30 View →
8-K 8-K 2026-03-30 View →
4 Insider transaction 2026-03-25 View →
8-K 8-K 2026-03-23 View →
8-K 8-K 2026-02-25 View →
8-K 8-K 2026-02-11 View →
4 Insider transaction 2026-02-06 View →
8-K 8-K 2026-02-06 View →
4 Insider transaction 2026-01-28 View →
4 Insider transaction 2026-01-28 View →
4 Insider transaction 2026-01-28 View →
4 Insider transaction 2026-01-28 View →
8-K 8-K 2026-01-28 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$1.06
Market Cap
$17.53 million
52-Week Range
$0.84 – $6.12
Average Volume
256K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.